PACAP Expression in an Auditory Neurocircuit Relay Center by Segil, Matthew N
University of Vermont 
ScholarWorks @ UVM 
UVM College of Arts and Sciences College 
Honors Theses Undergraduate Theses 
2018 
PACAP Expression in an Auditory Neurocircuit Relay Center 
Matthew N. Segil 
The University of Vermont 
Follow this and additional works at: https://scholarworks.uvm.edu/castheses 
Recommended Citation 
Segil, Matthew N., "PACAP Expression in an Auditory Neurocircuit Relay Center" (2018). UVM College of 
Arts and Sciences College Honors Theses. 47. 
https://scholarworks.uvm.edu/castheses/47 
This Undergraduate Thesis is brought to you for free and open access by the Undergraduate Theses at 
ScholarWorks @ UVM. It has been accepted for inclusion in UVM College of Arts and Sciences College Honors 
Theses by an authorized administrator of ScholarWorks @ UVM. For more information, please contact 
donna.omalley@uvm.edu. 











PACAP Expression in an Auditory Neurocircuit Relay Center 
Matthew N. Segil 











PACAP EXPRESSION IN AN AUDITORY NEUROCIRCUIT 2 
Abstract 
 
Pituitary adenylyl cyclase-activating polypeptide (PACAP) is a small pleiotropic 
neuropeptide found throughout the central and peripheral nervous system.  It binds with highest 
affinity to its complementary receptor, pituitary adenylyl cyclase-activating polypeptide receptor 
1.  Using PACAP-Cre transgenic mice, an adeno-assisted viral construct was injected into the 
diencephalon for Cre-dependent expression of mCherry fluorescent protein in PACAP-
expressing neurons.  We observed red mCherry fluorescence in PACAP expressing neurons in 
the suprageniculate (SG) thalamic nucleus, a component of the auditory sensory pathway.  The 
nucleus receives afferent fibers from the deep layers of the superior colliculus (SC) and sends 
axonal projections to various targets including the auditory cortex and posterior parietal cortex.  
Previous studies in hippocampal and limbic systems have shown that PACAP is co-expressed in 
glutamatergic neurons.   In coherence, inspection of Allen’s Brain Atlas for vesicular glutamate 
transporter (VGLUT) and glutamic acid decarboxylase (GAD) transcript expression, as markers 
for glutamate and GABA neurons, respectively, suggests that the PACAP expressing neurons are 
glutamatergic in nature.  The findings of this study are novel in identifying PACAP expression in 
an auditory relay nucleus.    
  




PACAP is a neuroendocrine peptide encoded by the gene ADCYAP1 (Hosoya et al., 
1992).  It was first isolated, as a chain of 38 and 27 amino acids, denoted as PACAP-38 and 
PACAP-27 respectively, from the ovine hypothalamus based on its abilities to stimulate cAMP 
production in anterior pituitary cells (Miyata et al., 1989).  The effects of PACAP are pleiotropic; 
a significant amount of literature exists on its involvement in homeostatic functions, stress 
circuitry, and neuromodulation of glutamate circuitry (Hammack et al., 2009; Huang, Waters, & 
Machaalani, 2017; Stella & Magistretti, 1996).   
PACAP is part of a superfamily of structurally related peptides that includes vasoactive 
intestinal peptide (VIP), glucagon, secretin, gastric inhibitory peptide, and growth hormone-
releasing hormone (Harmar et al., 1998).  Within the glucagon/secretin family, receptors and 
ligands exhibit a high degree of sequence homology. As reviewed by Laburthe, Couvineau, and 
Tan (2007), VIP and PACAP are structurally related neuropeptides with PACAP sharing 68% of 
its sequence identity with VIP.  The PACAP receptor also shares some amino acid and structural 
similarities with other related Class B G protein coupled receptors (GPCRs), including secretin 
and glucagon receptors.  Similar to other Class B receptors and unlike Class A GPCRs the PAC1 
receptor has a large N-terminal extracellular domain for high affinity ligand binding (Laburthe et 
al., 1996).  
Three G protein-coupled receptors, VPAC1, VPAC2, and PAC1 have been identified to 
bind to PACAP.  PACAP binds exclusively to the PAC1 receptor while VIP and PACAP have 
near equal high affinity for the VPAC1 and VPAC2 receptors (Harmar et al., 2012). The PAC1 
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receptor is highly abundant in neuroendocrine tissues such as the brain, pituitary system, and 
adrenal glands. The two VPAC receptors are expressed in the nervous system but mainly 
concentrated in peripheral tissues including lung, liver, and testis (Vaudry et al., 2009). These 
receptors utilize a variety of second messenger cascades to activate cellular pathways; in the case 
of PAC1, the pathway is linked predominantly to adenylyl cyclase and phospholipase C 
activities. 
PACAP acts in diverse pathways and is essential for postnatal survival.  A study by Gray, 
Cummings, Jirik, and Sherwood, (2001) showed that PACAP-knockout mice experienced an 
80% mortality rate in the first three postnatal weeks.  The authors findings suggest that this is 
due to a disruption in PACAP’s normal role as a regulator of lipid and carbohydrate metabolism.  




The suprageniculate (SG) nucleus is a thalamic relay center found dorsal to the medial 
geniculate nucleus (MGN).  From a rostral viewpoint, the SG appears between the 
lateroposterior nuclear complex  and the principal pretectal nucleus (Figure 1).  The majority of 
the SG is superior to the posterior thalamic nucleus (Neylon & Haight, 1983).  In the possum, the 
SG receives a strong input from the superior colliculus (SC), likely from the deep layers.  SG 
cortical projection neurons have been shown to respond to visual, somatosensory, and auditory 
stimulation in placental mammals as well, such as in cats and monkeys (Loe & Benevento, 1969; 
Sudakov, MacLean, Reeves, & Marino, 1971).  Considering these observations, it is likely that 
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the SG serves as a relay for multimodal sensory projections originating from the deep layers of 
the SC and projecting to their respective cortical regions: visual, auditory, and somatosensory. 
Visual stimulation has been observed to play an important role in affecting auditory 
perception, including the spatial localization of sounds (Howard & Templeton, 1966; Recanzone, 
2003).  This type of multimodal processing has been shown in visual-auditory interactions in the 
primary auditory cortex (Kayser, Petkov, & Logothetis, 2008).  These findings contribute to a 
body of evidence that suggests visual information is being projected to the auditory cortex, 
subsequently affecting processing of auditory stimuli.  Although the visual cortex does project 
directly to the auditory cortex (Bizley, Nodal, Bajo, Nelken, & King, 2007), a second major 
source of visual input stems from the SG (Smith, Manning, & Uhlrich, 2010).  
 Despite innervation from a visual relay center, it has been established that SG neurons in 
many mammals (such as cats) are primarily projecting to the auditory cortex (Benedek, Pereny, 
Kovacs, FischerSzatmari, & Katoh, 1997; Paroczy et al., 2006).  A robust innervation from SC 
layers to the SG is also present in rats (Linke, 1999).  Recent research has shown that rat SG 
cells then project to the auditory cortex, in particular layers I, V, and VI (Smith, Manning, & 
Uhlrich, 2010).  These results also show that SG axons are capable of innervating multiple 
cortical layers and may extend a considerable distance in layer I.  Importantly, researchers also 
found that these projections were non-GABAergic: meaning they are putatively glutamatergic. 
 
Auditory Pathway: 
The central auditory pathway begins with the ear.  Auditory information is processed and 
transduced by specialized inner ear hair cells; the signals are then relayed to the central auditory 
pathway by the vestibulocochlear nerve.  The vestibulocochlear nerve transmits afferent auditory 
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information to the cochlear nuclei.  Here, the auditory information splits; one pathway relays to 
the reticular formation, while the primary auditory pathway relays auditory information to the 
superior olivary nuclei.  Information is then relayed to the inferior colliculus (IC).  The IC then 
relays the auditory information through the brachium of the inferior colliculus to several 
thalamic nuclei, especially MGN.  From the thalamus, all auditory information is sent to the 
primary auditory cortices for conscious processing (Webster & Fay, 2013). 
The auditory cortex (AC) is located in the cerebrum and modulates attentional focus of 
the auditory pathway.  The AC sends descending projections down to brainstem nuclei to 
regulate auditory input and adapt to spatial cues (Mellott, Bickford, & Schofield, 2014).  The 
descending corticofugal projections from the AC can terminate onto the MGN or the IC.  They 
also project down to the nucleus of the brachium of the inferior colliculus.   
Hannibal (2002) found immunohistochemical evidence for PACAP expression in several 
regions of the auditory pathway, including the cochlear and vestibular nuclei.  PACAP 
expression was also found in cranial nerve VIII, the vestibulocochlear nerve.  Kawano et al., 
(2001) demonstrated that PACAP is present in the cochlea of rats.  In situ hybridization showed 
that components of the stria vascularis, spiral ganglion and marginal cells, expressed mRNA for 
PACAP. Additionally, PACAP is thought to act within the organ of Corti as a neuromodulator of 
afferent projections; it may also play a role in protection from excitotoxicity (Drescher et al., 
2006).  Furthermore, the Allen Brain Atlas has shown that several thalamic nuclei that are 
involved in sensory processing demonstrate PACAP expression; notably, these include the MGN 
and SG. 
 
PACAP Modulates Glutamate Receptor Function: 
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Chen, Buchanan, Ding, Hannibal and Gillette (1999) were among the first to show that 
PACAP plays an important role in modulating glutamate activity.  Chen et al., (1999) focused 
specifically on PACAP’s role controlling circadian activity phase shifts in the 
retinohypothalamic tract (RHT).  They were able to demonstrate that PACAP receptor-mediated 
processes can alter glutamate-generated phase shifts and amplitudes of circadian behavioral 
responses. 
Hannibal, Moller, Ottersen and Fahrenkrug (2000) showed that all PACAP expressing 
retinal ganglion cells were co-localized with glutamate.  The postulated role of PACAP in the 
RHT is to assist in the stimulation of the suprachiasmatic nucleus (SCN), which is primarily 
responsible for generating circadian rhythms.     
Michel, Itri, Han, Gniotczynski, and Colwell (2006) showed that PACAP is a strong 
modulator of glutamate activity in the SCN, especially during the early phase of subjective night.  
PACAP accomplishes this modulation by enhancing the evoked currents of both NMDA 
receptors (NMDAR) and AMPA receptors (AMPAR) in SCN neurons.  Evidence generated by 
this study suggested that the magnitude of AMPA currents is dependent on PAC1 receptor-
mediated processes, in particular, the adenylyl cyclase/cAMP-signaling cascade.   These changes 
in synaptic strength have been shown to occur via PKA mediated phosphorylation of AMPARs 
(Toda & Huganir, 2015). 
 Further evidence of PACAP’s ability to modulate glutamate signaling has been found in 
the hippocampus, where it modulates NMDARs and AMPARs.  In hippocampal CA1 pyramidal 
neurons, PACAP modulates AMPA receptor-mediated currents via PAC1 and VPAC2 receptors.  
Both of these pathways use cAMP/PKA cascades to affect change (Costa, Santangelo, Volsi, & 
Ciranna, 2009).  Costa et al., (2009) found that PACAP altered glutamate-induced signaling in 
PACAP EXPRESSION IN AN AUDITORY NEUROCIRCUIT 8 
AMPARs by reducing the amplitude and duration of generated EPSCs via VPAC2 receptors.  
When PKA was inhibited, the effect of PACAP was strongly reduced, suggesting that PACAP’s 
effects on these neurons are primarily postsynaptic.   
Macdonald et al., (2005) demonstrated that PACAP can enhance NMDA receptor-
mediated transmission on CA1 pyramidal neurons, primarily via PAC1 receptors.  Researchers 
administrated PACAP38 to the hippocampus; CA3 neurons were then found to have increased 
levels of Schaffer collaterals EPSCs.  PACAP38 also caused an increase of peak NMDAR 
currents in CA1 neurons.   
Although few studies have shown evidence of PACAP-mediated influence of AMPA 
currents, a growing line of evidence suggests that NMDA receptors are influenced by PACAP in 
many brain regions such as the SCN (Michel et al., 2006), hippocampus (Macdonald et al., 2005) 
and cerebellar regions (Llansola, Sanchez-Perez, Montoliu, & Felipo, 2004).  These studies in 
aggregate demonstrate the differential effects of PACAP on NMDA and AMPA receptors via 
PAC1 or VPAC2 receptors.  The purpose of the study herein is to identify where PACAP 




Materials and Methods 
 
Surgery: 
PACAP-Cre transgenic mice were received from Bradford Lowell (McLean Hospital, 
Tufts University; Krashes et al., 2014).  PACAP-Cre littermate (n=3; 6 weeks of age) mice were 
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thoroughly anesthetized with isoflurane (3-4%) before the surgical delivery of adeno-associated 
virus (AAV) vector (AAV-EF1a-DIO-mCherry) for Cre-dependent expression of the fluorescent 
tracer mCherry.  Mice were secured in place using stereotaxic equipment, an incision was then 
made along the sagittal surface of the scalp.  A small hole was drilled at the coordinates in mm 
from Bregma, AP -3.28, ML 1.75, and DV -2.75 from the surface of the dura.  A 1 μL Hamilton 
syringe was then used to deliver 0.5μL of AAV.  The incision was then closed and the mouse 
was allowed a week to recover. 
 
Perfusion: 
Mice were euthanized via perfusion.  Each mouse was anesthetized with isoflurane; an 
incision was then made beneath the rib cage of the animal.  The fascia tissue surrounding the 
heart was opened, a butterfly needle was then inserted into the left ventricle.  Saline was injected 
into the left ventricle as an incision was made simultaneously in the right atrium.  Once the saline 
flush was completed, the syringe was replaced with paraformaldehyde (4%) for perfusion 
fixation.  The cranium was opened along the suture lines and the brain was removed. 
 
Fixation, cryosectioning and microscopy: 
 The brain was placed in a fixative solution (4% paraformaldehyde) for 24 hours.  To 
ensure cryoprotection, the brain was then placed in three consecutive sucrose solutions, 10%, 
20%, and 30% respectively, for 24 hours each.  Once the brain was fully saturated, it was 
removed and frozen using Tissue-Tek O.C.T. compound cryostat gel and dry ice.  The brain was 
then sliced on a Cryostat machine at a thickness of 40 μm.  Brain slices were mounted on 
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microscope slides directly after slicing.  Slides were observed and micrographed using an 





 Microinfusion of the AAV-EF1a-DIO-mCherry vector into the diencephalon of the 
PACAP-Cre mice allowed the Cre-dependent expression of the fluorescent mCherry protein in 
PACAP-expressing neurons.   One week after infusions, the brains were harvested and prepared 
as described in Methods; they were then cryosectioned and inspected on a fluorescent 
microscope for mCherry expression.  From adjacent sections, robust mCherry fluorescence was 
observed in isolated PACAP neurons in the suprageniculate thalamic nucleus (Figure 2A – 2F).  
The expression was compact and discrete; the right hand panels are higher magnifications of the 
expression sites to better illustrate the labeling.  The mCherry signal was cytoplasmic and 
extended into a few processes and as the labeled process could not be traced for any significant 
length, it is unclear if these are PACAP projection neurons or interneurons in the circuit.  These 
data correlated well with the mouse brain PACAP mRNA in situ hybridization data in the Allen 
Brain Atlas demonstrating PACAP transcript expression in the same suprageniculate nucleus 
(Figure 3, circumscribed area).  Not shown by our vector injections but illustrated in the Atlas, 
the ventral medial geniculate (MGV) nucleus may also contain PACAP expressing neurons; 
notably, PACAP expression is not evident in dorsal medial geniculate (MGD) nucleus from the 
Atlas or by our injections. 
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 For many of the central PACAP neurocircuits examined to date PACAP is localized 
predominantly to glutamatergic neurons.  Although time restrictions did not allow us to 
immunocytochemically process the mCherry-labeled sections for glutamatergic and GABAergic 
markers, inspection of VGLUT1/VGLUT2 and GAD transcript expression patterns in the Allen 
Brain Atlas revealed that the expression of excitatory or inhibitory neuronal transcripts in the 
suprageniculate nucleus appears unique (Figure 4, circumscribed area).  The suprageniculate 
nucleus does not appear to express VGLUT1, but robustly expresses VGLUT2; the expression of 
GAD transcripts does not appear to coincide with those for PACAP-mCherry.  Considering the 
similarities with VGLUT2 transcript localization patterns, the PACAP expressing neurons in the 
suprageniculate nucleus appear glutamatergic in nature and coincide with PACAP mechanisms 





By using PACAP-Cre transgenic mice, we observed PACAP activity in the SG thalamic 
nucleus.  The SG receives inputs from the deep layers of the SC and projects to the auditory 
cortex and posterior parietal cortex.  Smith, Manning, and Uhlrich (2010) have shown that cells 
in the SG project to layers I, V, and VI of the auditory cortex; they also demonstrated that these 
projections were non-GABAergic.  Drawing from results found in the Allen Brain Atlas, these 
projections are putatively glutamatergic.  
The VGLUT2 glutamate transporter protein was found in particular abundance around 
the region of the SG.  The GABA synthesis enzyme, GAD, and glutamate transporter, VGLUT1, 
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were both found in significantly lower concentrations in this region.  The Atlas illustrated that 
the MGV also contains PACAP expressing neurons, although neither the Atlas, nor our 
injections showed PACAP expression in the MGD. 
The MGV and MGD are non-GABAergic thalamocortical relay centers in the auditory 
pathway which receive projections from the IC.  The MGV and MGD project primarily to layers 
III and IV of the auditory cortex (Smith, Uhlrich, Manning, & Banks, 2012).  Interestingly, the 
SG terminates primarily in layers I, V, and VI (Smith, Manning, & Uhlrich, 2010), suggesting 
that the MGV and MGD are acting in a different circuit than the SG. Smith, Uhlrich, Manning, 
and Banks (2012) found that MGD terminals in the auditory cortex are larger than those of the 
MGV and synapse more frequently in the posterodorsal (PD) region of the cortex.  Kimura et al., 
(2010) have postulated that the MGD projections to the PD region of the cortex are involved in 
spatial processing of auditory information. Presently, it is unclear why PACAP transcripts are 
found in MGV but absent in the MGD, particularly because, like the SG, the MGD is involved in 
auditory spatial processing.  Differences in PACAP expression may be due to evolutionary 
divergence of communication in auditory pathways.  The roles of PACAP in these pathways are 
novel but require additional investigation. 
Considering the results of our study and the Atlas, it is likely that PACAP and glutamate 
are colocalized in the SG.  Here PACAP may play a modulatory role in glutamate signaling.  
PACAP has been shown to modulate glutamate signaling via AMPA in the SCN (Michel et al., 
2006) and NMDA receptors in hippocampal CA3 and CA1 neurons (Macdonald et al., 2005).  
The presence of PACAP in the SG suggests a role in glutamate modulation.   
 To date, the role of NMDA receptors in glutamate modulation appears to be particularly 
promising.  PACAP acts in various, conflicting roles and exhibits the ability to both reduce or 
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enhance EPSCs in the hippocampus (Costa et al., 2009; Macdonald et al., 2005).  PACAP has 
been shown to act as an inhibitory (Kondo et al., 1997), excitatory (Roberto and Brunelli, 2000) 
and biphasic (Roberto et al., 2001) modulator of synaptic transmission in CA1 neurons.  The 
opposing roles of PACAP demonstrated in these studies may be due to differing concentrations 
of PACAP at the active site or the research techniques used. 
 Findings from PACAP activity in the hippocampus suggest that PACAP acts primarily as 
a post-synaptic modifier of glutamate transmission.  Ciranna and Cavallaro (2003) demonstrated 
that in the presence of the PKA-inhibitor cAMPS-Rp, PACAP-containing cells showed 
significantly lower amplitude EPSCs in CA1 neurons.  The PACAP activity that is not inhibited 
by administration of cAMPS-Rp may be acting at a presynaptic site.  This line of evidence is 
supported by Otto, Zuschratter, Gass and Schutz (1999) whose immunohistochemical analysis 
localized PACAP activity around synaptic vesicles in the CA3 region.  
 PACAP’s activity at the postsynaptic site is likely occurring at PAC1 and VPAC2 
receptors (Costa et al., 2009).  After the PACAP ligand binds, it has been suggested that the 
PKA-mediated signaling cascade releases the RACK1 scaffolding protein from Fyn and the 
NR2B subunit of the NMDA receptor (Yaka, He, Phamluong, & Ron, 2003).  This step allows 
Fyn to phosphorylate NR2B which then results in an increase of EPSCs through the NMDA 
channel.  This mechanism provides a putative explanation for PACAP’s ability to modulate CA1 
neurons in an excitatory fashion.   
 Given the high conservation of pharmacological processes, it is likely that PACAP 
activity in the SG is acting in a similar way to that of the hippocampus.  In the SG, PACAP could 
play a diverse cast of roles in altering rates of synaptic transmission.  This would mean that 
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PACAP activity in the SG assists in fine tuning response spatial localization of sounds, response 
orientation, auditory focus, multimodal processing and other functions. 
 The exact physiological role of PACAP in the SG is still unknown.  Current literature 
suggests that PACAP activity in the SG may be modulating glutamate activity via NMDA or/and 
AMPA receptors, in an excitatory, inhibitory, or biphasic manner.  Future studies investigating 
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Figure 1: Parasagittal view of the bat brain with lemniscal pathway (white) and extralemniscal 
pathway (black).  CN, cochlear nucleus; SC, superior colliculus; SG, suprageniculate nucleus.  
Adapted from Casseday et al., (1989). 
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Figure 2:  Cre-induced mCherry expression in PACAP containing cells of the suprageniculate 
thalamic nucleus.  Observed with Cy3 or Texas Red filter sets.  Right panel shows increased 
magnification of left panel results. 
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Figure 3:  Allen Brain Atlas depiction of the expression of PACAP mRNA transcripts in the 
suprageniculate thalamic nucleus of the mouse brain.  Dotted circle emphasizes the observed 
region: the suprageniculate thalamic nucleus. 
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Figure 4:  Allen Brain Atlas in situ hybridization for VGLUT1, VGLUT2, and GAD mRNA 
transcripts in the mouse brain.  Dotted circle emphasizes the region of observation: the 
suprageniculate thalamic nucleus. 
 
 
